Presentation and Status in Health Basket
30 x 50 mg
30 x 100 mg
See prescribing information for full details.
NIDDM in patients inadequately controlled by diet alone, or on diet and oral hypoglycemic agents.
Hypersensitivity, pregnancy, lactation, chronic digestive system disorders, liver function disorders, renal insufficiency.
See literature for full details.
When a high dosage is taken or when the medicdbine is taken concomitantly with other anti-diabetic medicdbations, hypoglycemia may occur, in which case glucose/dextrose should be administered rather than sucrose. May cause elevation in liver enzymes. Therefore, liver enzymes should be monitored during the first 6-12 months of treatment. Safety and efficacy in children under 18 years have not been established.
Increased flatulence, diarrhea, other abdominal aches. See literature for full details.
Sulfonylureas, metformin, insulin, cholestyramine, digoxin, intestinal absorbents, and digestive enzyme preparations, activated charcoal preparations, neomycin.